Evidence map›Paper›PMID 26136900›Full record

ArticleExperimental and therapeutic medicine2015

Metabolic regulation of magnolol on the nuclear receptor, liver X receptor.

N A Xie, Chunyang Hu, Anran Guo, Hao Liang, Pengcheng DU, Guotian Yin

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. The complete chloroplast genome of wildMitochondrial DNA. Part B, Resources · 2021
    Article
  6. Insights on the Multifunctional Activities of Magnolol.BioMed research international · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

N A XieDepartment of Cardiology, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan 453000, P.R. China.
Chunyang HuDepartment of Cardiology, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan 453000, P.R. China.
Anran GuoDepartment of Internal Medicine, Luyi Xian People's Hospital, Zhoukou, Henan 477200, P.R. China.
Hao LiangDepartment of Internal Medicine, Luyi Xian People's Hospital, Zhoukou, Henan 477200, P.R. China.
Pengcheng DUDepartment of Cardiology, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan 453000, P.R. China.
Guotian YinDepartment of Cardiology, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan 453000, P.R. China.
Xinxiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to investigate whether magnolol, the essential component of the traditional Chinese medicine,

Indexed as

cholesterolliver X receptor αMagnolia officinalismagnolol

Identifiers

PMID26136900
PMCPMC4471739
OpenAlexW2102981241

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.